Prognostic value of serum soluble interleukin-2 receptor level in patients with diffuse large B cell lymphoma, treated with CHOP- or RCHOP-based therapy-Reference-Cited by-同舟云学术

Prognostic value of serum soluble interleukin-2 receptor level in patients with diffuse large B cell lymphoma, treated with CHOP- or RCHOP-based therapy

Published:2008-01 Issue:7 Volume:49 Page:1345-1351
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Oki Yasuhiro,Kato Harumi,Matsuo Keitaro,Kuwatsuka Yachiyo,Taji Hirofumi,Yamamoto Kazuhito,Kagami Yoshitoyo,Morishima Yasuo

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190802108888

Reference25 articles.

1. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

2. The molecular basis for the generation of the human soluble interleukin 2 receptor

3. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival.

4. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in biology, diagnosis and treatment of DLBCL;Annals of Hematology;2024-07-17

2. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17

3. Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy;Scientific Reports;2023-08-22

4. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era;Leukemia Research;2020-07

5. Measurement of the concentration of serum soluble interleukin-2 receptor alpha chain in dogs with lymphoma;Veterinary Immunology and Immunopathology;2020-07